{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:33:26Z","timestamp":1777336406810,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research Bonn Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001663","name":"Volkswagen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jcf.2025.02.014","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T07:26:18Z","timestamp":1739949978000},"page":"212-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The multiple tales on sweat chloride in cystic fibrosis"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2566-8758","authenticated-orcid":false,"given":"Burkhard","family":"T\u00fcmmler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2025.02.014_bib0001","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1542\/peds.23.3.545","article-title":"A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis","volume":"23","author":"Gibson","year":"1959","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2025.02.014_bib0002","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1164\/rccm.201603-0459OC","article-title":"Sources of variation in sweat chloride measurements in cystic fibrosis","volume":"194","author":"Collaco","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2025.02.014_bib0003","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jcf.2024.01.012","article-title":"ECFS standards of care on CFTR-related disorders: towards a comprehensive program for affected individuals","volume":"23","author":"De Wachter","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.02.014_bib0004","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jcf.2015.01.005","article-title":"Association of sweat chloride concentration at time of diagnosis and CFTR genotype with mortality and cystic fibrosis phenotype","volume":"14","author":"McKone","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.02.014_bib0005","doi-asserted-by":"crossref","first-page":"00587","DOI":"10.1183\/23120541.00587-2024","article-title":"Variability in disease severity among cystic fibrosis patients carrying residual-function variants: data from the European cystic fibrosis society patient registry","volume":"11","author":"Mei-Zahav","year":"2025","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jcf.2025.02.014_bib0006","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1203\/00006450-198709000-00007","article-title":"Hyposecretion of beta-adrenergically induced sweating in cystic fibrosis heterozygotes","volume":"22","author":"Behm","year":"1987","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jcf.2025.02.014_bib0007","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jcf.2022.02.001","article-title":"How the sweat gland reveals levels of CFTR activity","volume":"21","author":"Wine","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.02.014_bib0008","series-title":"Mukoviszidose. Cystische Fibrose. II. Deutsches Symposium","first-page":"12","article-title":"Mikropunktionsuntersuchungen an Schwei\u00dfdr\u00fcsen von Mukoviszidosepatienten und gesunden Versuchspersonen","author":"Schulz","year":"1968"},{"key":"10.1016\/j.jcf.2025.02.014_bib0009","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/301421a0","article-title":"Chloride impermeability in cystic fibrosis","volume":"301","author":"Quinton","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.jcf.2025.02.014_bib0010","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jcf.2021.10.005","article-title":"CFTR modulation with elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis assessed by the \u03b2-adrenergic sweat rate assay","volume":"21","author":"Pallenberg","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.02.014_bib0011","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2020-000736","article-title":"Intestinal current measurement and nasal potential difference to make a diagnosis of cases with inconclusive CFTR genetics and sweat test","volume":"7","author":"Minso","year":"2020","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jcf.2025.02.014_bib0012","article-title":"Elexacaftor\/tezacaftor\/ivacaftor efficacy in intestinal organoids with rare CFTR variants in comparison to CFTR-F508del and CFTR-wild type controls","author":"Kroes","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.02.014_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2024.12.006","article-title":"Sweat chloride reflects CFTR function and correlates with clinical outcomes following CFTR modulator treatment","author":"Zemanick","year":"2025","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.02.014_bib0014","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jcf.2024.02.001","article-title":"Heterogeneity of CFTR modulator-induced sweat chloride concentrations in people with cystic fibrosis","volume":"23","author":"Zemanick","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.02.014_bib0015","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1164\/rccm.202110-2249OC","article-title":"Effects of elexacaftor\/tezacaftor\/ivacaftor therapy on CFTR function in patients with cystic fibrosis and one or two F508del alleles","volume":"205","author":"Graeber","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2025.02.014_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000529524","article-title":"Survival-adjusted FEV1 and BMI percentiles for patients with cystic fibrosis before the era of triple CFTR modulator therapy in Germany","volume":"102","author":"Dittrich","year":"2023","journal-title":"Respiration"},{"key":"10.1016\/j.jcf.2025.02.014_bib0017","article-title":"Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials","author":"Keating","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2025.02.014_bib0018","article-title":"Vanzacaftor-tezacaftor- deutivacaftor for children aged 6-11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial","author":"Hoppe","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2025.02.014_bib0019","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01454-22","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor therapy on the cystic fibrosis airway microbial metagenome","volume":"10","author":"Pallenberg","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jcf.2025.02.014_bib0020","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jcf.2024.05.002","article-title":"Impact of extended elexacaftor\/tezacaftor\/ivacaftor therapy on the gut microbiome in cystic fibrosis","volume":"23","author":"Marsh","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.02.014_bib0021","doi-asserted-by":"crossref","DOI":"10.1148\/ryct.230104","article-title":"PREFUL MRI for monitoring perfusion and ventilation changes after elexacaftor-tezacaftor-ivacaftor therapy for cystic fibrosis: a feasibility study","volume":"6","author":"Dohna","year":"2024","journal-title":"Radiol Cardiothorac Imaging"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325000645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325000645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:35:04Z","timestamp":1777332904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199325000645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1569199325000645"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2025.02.014","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The multiple tales on sweat chloride in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2025.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}